FDA and EMA Requirements for Companion Biomarker Validation
FDA and EMA Requirements for Companion Biomarker Validation Navigating Regulatory Requirements for Companion Biomarker Validation Introduction to Companion Biomarkers and Regulatory Oversight Companion biomarkers are critical tools in the era of precision medicine, enabling targeted therapies by identifying patients most likely to benefit. Both the U.S. Food and Drug Administration (FDA) and the European Medicines…
Read More “FDA and EMA Requirements for Companion Biomarker Validation” »